Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$77.10 0.41 (0.53%) as of 4:30 Wed 6/26


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 110.25(B)
Last Volume: 6,013,077 Avg Vol: 8,376,873
52 Week Range: $48.64 - $77.42
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 304,513 503,645 996,293 2,118,674
Total Sell Value $22,679,618 $34,760,114 $60,765,476 $110,963,213
Total People Sold 9 10 11 13
Total Sell Transactions 14 26 43 79
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 2009
  Page 52 of 81  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Nicholas Peter M Director   –       •      –    2010-03-22 4 AS $7.01 $175,303 I/I (25,000) 10,181,021     -
   Abele John E Director   –       •      –    2010-03-22 4 AS $7.01 $527,593 I/I (75,000) 6,441,949     -
   Abele John E Director   –       •      –    2010-03-19 4 AS $7.12 $534,330 I/I (75,000) 6,516,949     -
   Nicholas Peter M Director   –       •      –    2010-03-19 4 AS $7.13 $178,125 I/I (25,000) 10,206,021     -
   Nicholas Peter M Director   –       •      –    2010-03-18 4 AS $6.90 $172,603 I/I (25,000) 10,231,021     -
   Abele John E Director   –       •      –    2010-03-18 4 AS $6.90 $519,398 I/I (75,000) 6,591,949     -
   Abele John E Director   –       •      –    2010-03-16 4 D $0.00 $0 D/D (100,000) 13,643,721     -
   Nicholas Peter M Director   –       •      –    2010-03-16 4 D $0.00 $0 I/I (100,000) 10,256,021     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       –      –    2010-03-15 4 AS $6.40 $18,963 D/D (2,963) 51,908     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       –      –    2010-03-15 4 OE $6.13 $18,148 D/D 2,963 54,871     -
   Fitzgerald Joseph Michael SVP & President, Endovascular   •       –      –    2010-03-01 4 D $7.77 $8,578 D/D (1,104) 35,330     -
   Fitzgerald Joseph Michael SVP & President, Endovascular   •       –      –    2010-03-01 4 OE $0.00 $0 D/D 3,375 36,434     -
   Pratt Timothy A. EVP, GC & Chief Admin Officer   •       –      –    2010-02-24 4 D $7.80 $8,923 D/D (1,144) 11,934     -
   Pratt Timothy A. EVP, GC & Chief Admin Officer   •       –      –    2010-02-24 4 OE $0.00 $0 D/D 3,012 13,078     -
   Gilbert James EVP, Strategy & Business Dev   •       –      –    2010-02-24 4 D $7.80 $8,533 D/D (1,094) 67,613     -
   Gilbert James EVP, Strategy & Business Dev   •       –      –    2010-02-24 4 OE $0.00 $0 D/D 3,314 68,707     -
   Pedersen John B. Pres,Uro & Womens Health   •       –      –    2010-02-24 4 D $7.80 $3,931 D/D (504) 1,441     -
   Pedersen John B. Pres,Uro & Womens Health   •       –      –    2010-02-24 4 OE $0.00 $0 D/D 1,326 1,945     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       –      –    2010-02-24 4 D $7.80 $9,142 D/D (1,172) 51,908     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       –      –    2010-02-24 4 OE $0.00 $0 D/D 3,012 53,080     -
   Phalen Michael P. SVP & President, Endoscopy   •       –      –    2010-02-24 4 D $7.80 $13,650 D/D (1,750) 24,696     -
   Phalen Michael P. SVP & President, Endoscopy   •       –      –    2010-02-24 4 OE $0.00 $0 D/D 4,699 26,446     -
   Pucel Kenneth EVP, Global Operations   •       –      –    2010-02-24 4 D $7.80 $7,465 D/D (957) 61,540     -
   Pucel Kenneth EVP, Global Operations   •       –      –    2010-02-24 4 OE $0.00 $0 D/D 3,012 62,497     -
   Colen Fred EVP & Chief Technology Officer   •       –      –    2010-02-24 4 D $7.80 $7,683 D/D (985) 64,842     -
  2009 Records found
  Previous  50  51  52  53  54  55  56  57  58  59  Next   
  Page 52 of 81
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us